Human medicines European public assessment report EPAR Zessly infliximab Arthritis PsoriaticPsoriasisCrohn DiseaseArthritis RheumatoidColitis UlcerativeSpondylitis Ankylosing Date of authorisation 18052018 Revision 2 Status Authorised
↧